XBI

Biotech Breakdown: Seeking Relief Today

At Close: IBB down 2.35% to 342 at May bottom, XBI up 0.64% to 218
—-
Two Hours to Go 2:15p EDT, NASDAQ Down 1.79% at 4792, IBB at $349
Biotech Breakdown: Relief Today Or Another Head Fake?
Biotech stocks are trying to hold the May lows with the IBB at $342 but now at $349. There is bit of buying today and most biotechnology […]

Why This Biotech ETF Keeps Surging | ETF Trends

Why This Biotech ETF Keeps Surging | ETF TrendsHere is a new biotech ETF stock that is worth buying, BBP. They seem to be doing well at picking winners. I plan to buy BBP soon even though I already own BIB and XBI. I believe good biotech stocks will outperform the general market easily.

View post – 

Why This Biotech ETF Keeps Surging […]

Biotech Stocks Lose Momentum with Greece Crisis; Blockbuster Immunotherapy Deal

Biotech Stocks in Broad Sell-Off
The biotech sector is usually immune to macro events but today the crisis in Greece gave investors an excuse to take profits. Many biotech stocks and ETFs were down over 3% faring worse than the NASDAQ down 2.4%. The sector, as tracked by IBB, is still up 18.87% YTD after hitting a high of 383 on […]

Is Biotech Finally In A Bubble? | Seeking Alpha

Is Biotech Finally In A Bubble? | Seeking AlphaDoctoRx has written an outstanding article on the biotech sector. I agree 100% with the doctor that biotech stocks are worth a good portion of your portfolio. I own XBI, the small cap biotech ETF, and BIB, the 2x leveraged ETF for large cap biotech stocks. These two stocks have far outperformed […]

small cap stocks and biotech stocks

So, today the small caps index (RUT) (IWM) breaks out to all time highs, and the same for the Nasdaq Biotech Index (NBI) (IBB). The S&P Biotech Index ($SPSIBI) (XBI) was already up there. This has the potential to become a melt up, if volume breadth accelerates. …it is all ‘blue sky’.

Jump to original – 

small cap stocks and biotech stocks

See which […]

Biotech Bubble; China Crash; Rate Rumble: How Goldman Is Hedging The "What Ifs"

It is no secret that in recent weeks Goldman has been particular bearish (if only to the outside world), with statements such as the following by chief equity strategist David Kostin:

… by almost any measure, US equity valuations look expensive. The typical stock in the S&P 500 trades at 18.1x forward earnings, ranking at the 98th percentile of historical valuation […]

Biotech ETF Trending Shows Shift To Speculative Stocks: XBI

Updated 6/10 Biotech ETFs lag overall in 1.4% rally. Materials, financials and technology lead. Large cap biotechs doing well.
Rayno portfolio winners today: ALXN, BIIB, GILD, RHHBY etc
Rapid Fire Re-Balancing of ETFs into More Speculative Names
Is the Tail Wagging the Dog?
We have published a number of reports on Life Science ETFs (2/4/15) in the past and noticed changes lately that reflect a […]

Biotech Bubble Buckles: Tumbles Almost 7% To 3-Week Lows | Zero …

Biotech stocks have been surging since their mid-March plunge (back below the 50DMA), but it appears that is at an end as XBI – the SPDR Biotech ETF – is now down almost 7% from Friday’s highs on heavy volume (and back below the 50DMA once again).Which has smashed XBI back below its 50DMA on very heavy volume..This is a […]

Biotech Bubble Buckles: Tumbles Almost 7% To 3-Week Lows

Biotech stocks have been surging since their mid-March plunge (back below the 50DMA), but it appears that is at an end as XBI – the SPDR Biotech ETF – is now down almost 7% from Friday’s highs on heavy volume (and back below the 50DMA once again).Which has smashed XBI back below its 50DMA on very heavy volume..This is a […]

Biotech Bull Market: Trends to Watch in 2015… #3

Biotech Sector Moves Up In Tiny Steps
Risk Remains On
AACR Next Week Will Move Cancer Stocks
Biotech indices and ETFs are trying to hit new highs but momentum is easing and trading is choppy. Nonetheless we are moving up from the brief correction near channel lows at the end of Q1. Sentiment remains strong.
Here is a review of the Five Trends we […]